Early changes in human myocardial nuclei after doxorubicin
- PMID: 6861067
- DOI: 10.1002/1097-0142(19830715)52:2<215::aid-cncr2820520206>3.0.co;2-f
Early changes in human myocardial nuclei after doxorubicin
Abstract
Ten nuclei from the endomyocardial biopsies for each of the following 32 patients were examined by electron microscopy: seven patients before and then four and 24 hours after treatment with first-dose doxorubicin; seven patients before and four and 24 hours after treatment with first-dose doxorubicin plus N-acetyl cysteine; nine patients with doxorubicin induced cardiomyopathy; and nine patients with idiopathic congestive cardiomyopathy. Five criteria were used to semiquantitatively compare nuclei and nucleoli from each group. The most dramatic changes in nuclear and nucleolar morphology were seen four hours after doxorubicin administration. Nucleoli were smaller, contracted or segregated and contained fewer fibrillar centers and a collapsed or fragmented nucleolonema. The addition of N-acetylcysteine to treatment did not alter these results. By 24 hours, nuclei had returned to the pre-treatment status. Long-term doxorubicin therapy produced increased chromatin clumping and slightly contracted nucleoli. The idiopathic congestive cardiomyopathic nuclei differed significantly from these doxorubicin cardiomyopathic nuclei in the decreased amount of chromatin clumping and the increase in fibrillar centers and nucleonema pattern. It is concluded from this study that: (1) doxorubicin markedly alters the morphology of the human myocardial nucleus and nucleolus four hours after treatment, but these changes diminish by 24 hours; (2) N-acetylcysteine treatment fails to prevent these changes; and (3) the nuclei and nucleoli of chronic doxorubicin-induced cardiomyopathy differ significantly from other congestive cardiomyopathies, but do resemble changes seen four hours after the first dose of doxorubicin.
Similar articles
-
Differentiating characteristics of myocardial nuclei in cardiomyopathy.Hum Pathol. 1983 Nov;14(11):974-83. doi: 10.1016/s0046-8177(83)80177-4. Hum Pathol. 1983. PMID: 6629369
-
Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration.Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1093-7. Cancer Treat Rep. 1981. PMID: 7296554
-
Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine.J Natl Cancer Inst. 1983 Nov;71(5):917-20. J Natl Cancer Inst. 1983. PMID: 6580492 Clinical Trial.
-
Doxorubicin (adriamycin) cardiomyopathy.West J Med. 1983 Sep;139(3):332-41. West J Med. 1983. PMID: 6356608 Free PMC article. Review.
-
Molecular mechanism of doxorubicin-induced cardiomyopathy - An update.Eur J Pharmacol. 2018 Jan 5;818:241-253. doi: 10.1016/j.ejphar.2017.10.043. Epub 2017 Oct 23. Eur J Pharmacol. 2018. PMID: 29074412 Review.
Cited by
-
Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes.Sci Rep. 2016 May 4;6:25333. doi: 10.1038/srep25333. Sci Rep. 2016. PMID: 27142468 Free PMC article.
-
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma.Clin Cancer Res. 2021 Jul 15;27(14):3854-3860. doi: 10.1158/1078-0432.CCR-20-4621. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766818 Free PMC article. Clinical Trial.
-
A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs.Biomater Res. 2023 Dec 15;27(1):133. doi: 10.1186/s40824-023-00465-9. Biomater Res. 2023. PMID: 38102651 Free PMC article.
-
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes.Sci Rep. 2017 Mar 16;7:44735. doi: 10.1038/srep44735. Sci Rep. 2017. PMID: 28300219 Free PMC article.
-
Risk of anthracycline-induced cardiac dysfunction in adolescent and young adult (AYA) cancer survivors: role of genetic susceptibility loci.Pharmacogenomics J. 2024 Jun 29;24(4):21. doi: 10.1038/s41397-024-00343-0. Pharmacogenomics J. 2024. PMID: 38951505 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources